ALNYLAM PHARMACEUTICALS, INC.

ALNY · Nasdaq · SIC 2834: Pharmaceutical Preparations
208
SEC Filings

Business Summary

PARTI Overview Alnylam Pharmaceuticals, Inc. (also referred to as Alnylam, the Company, we, our or us) is a global commercial-stage biopharmaceutical company developing novel therapeutics based on ribonucleic acid interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. By harnessing the RNAi pathway, we have pioneered a new class of innovative medicines, known as RNAi therapeutics. RNAi therapeutics a...

Next Earnings

Q2 FY2026 — expected 2026-09-20

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionALNYdiscussed_in_filing Cybersecurity
topic_mentionALNYdiscussed_in_filing Trusted Computing
topic_mentionALNYdiscussed_in_filing Blockchain & Crypto
topic_mentionALNYdiscussed_in_filing Regulation
topic_mentionALNYdiscussed_in_filing Healthcare & Bio
topic_mentionALNYdiscussed_in_filing Cybersecurity
topic_mentionALNYdiscussed_in_filing Trusted Computing
topic_mentionALNYdiscussed_in_filing Blockchain & Crypto
topic_mentionALNYdiscussed_in_filing Regulation
topic_mentionALNYdiscussed_in_filing Healthcare & Bio
topic_mentionALNYdiscussed_in_filing Cybersecurity
topic_mentionALNYdiscussed_in_filing Trusted Computing
topic_mentionALNYdiscussed_in_filing Blockchain & Crypto
topic_mentionALNYdiscussed_in_filing Regulation
topic_mentionALNYdiscussed_in_filing Healthcare & Bio
topic_mentionALNYdiscussed_in_filing Cybersecurity
topic_mentionALNYdiscussed_in_filing Trusted Computing
topic_mentionALNYdiscussed_in_filing Blockchain & Crypto
topic_mentionALNYdiscussed_in_filing Regulation
topic_mentionALNYdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-122025-12-310001628280-26-007497EDGAR108K words
2025-02-132024-12-310001178670-25-000026EDGAR—
2024-02-152023-12-310001178670-24-000008EDGAR—
2023-02-232022-12-310001178670-23-000005EDGAR—
2022-02-102021-12-310001178670-22-000013EDGAR—
2021-02-112020-12-310001178670-21-000010EDGAR—
2020-02-132019-12-310001178670-20-000004EDGAR—
2019-02-142018-12-310001564590-19-003022EDGAR—
2018-02-152017-12-310001564590-18-002152EDGAR—
2017-02-152016-12-310001564590-17-001649EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-302025-09-300001628280-25-047345EDGAR62K words
2025-07-312025-06-300001178670-25-000090EDGAR—
2025-05-012025-03-310001178670-25-000052EDGAR—
2024-10-312024-09-300001178670-24-000053EDGAR—
2024-08-012024-06-300001178670-24-000041EDGAR—
2024-05-022024-03-310001178670-24-000023EDGAR—
2023-11-022023-09-300001178670-23-000023EDGAR—
2023-08-032023-06-300001178670-23-000015EDGAR—
2023-05-042023-03-310001178670-23-000011EDGAR—
2022-10-272022-09-300001178670-22-000026EDGAR—
2022-07-282022-06-300001178670-22-000020EDGAR—
2022-04-282022-03-310001178670-22-000016EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-040001628280-26-014728EDGAR1K words
2026-02-120001628280-26-007491EDGAR—
2026-01-120001628280-26-001755EDGAR—
2025-12-110001193125-25-315047EDGAR—
2025-12-030001628280-25-055084EDGAR—
2025-10-300001628280-25-047342EDGAR—
2025-10-030001193125-25-230201EDGAR—
2025-09-120001193125-25-202366EDGAR—
2025-09-100001193125-25-199686EDGAR—
2025-07-310001178670-25-000089EDGAR—

208 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001178670
TickerALNY
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 64d7b3e088e7dc91f01bc711069eeea87b7339a196833aea5b185809e685bf0c
parent: 8ec9b7a48f2d81e41e5a96bd2e9ce40ced36d100b08e685910b7f089de776c7b
content hash: d9a32eb85f5ac83993c27e5ae690ab59e9e9f9335c0825aceb0edf5309cddec9
signed: 2026-04-13T04:43:35.899Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf